a year ago
NFLX
AnalystsVikram KesavabhotlaVikram Kesavabhotla's Stock Forecasts
AnalystsVikram Kesavabhotla
Analyst Ranking
Top 43%
#2366 out of 5510 analysts
Average Return
+0.34%
Win Rate
42%24 out of 57
Risk vs Reward
Poor
Good
Vikram Kesavabhotla's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Spotify Technology SaSPOT | +151.77% | $198.05 | $498.63 | 2023-12-08 - 2024-12-06 | Buy |
Signify Health IncSGFY | +126.99% | $12.82 | $29.10 | 2022-05-16 - 2022-09-06 | Buy |
Spotify Technology SaSPOT | +108.95% | $156.34 | $326.68 | 2023-06-05 - 2024-06-04 | Buy |
Godaddy IncGDDY | +104.74% | $92.86 | $190.12 | 2023-11-21 - 2024-11-20 | Buy |
Godaddy IncGDDY | +90.50% | $111.57 | $212.54 | 2024-02-14 - 2025-02-13 | Buy |
Vikram Kesavabhotla Analyst Color
Get additional color on Vikram Kesavabhotla's coverage of popular stocks
a year ago
WIX
a year ago
NFLX
a year ago
SPOT
2 years ago
TTD
2 years ago
NFLX
3 years ago
SPOT
3 years ago
NFLX
3 years ago
SPOT
Vikram Kesavabhotla's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Omada Health IncOMDA | 2 | Hold | $25.00 | +16.28% | Maintains | a month ago |
Netflix IncNFLX | 5 | Buy | $90.00 | +18.41% | Maintains | 2 months ago |
Lionsgate Studios CorpLION | 4 | Buy | $20.00 | +79.37% | Maintains | 3 months ago |
Hinge Health IncHNGE | 2 | Hold | $65.00 | -26.35% | Maintains | 3 months ago |
Roku IncROKU | 7 | Hold | $160.00 | +3.82% | Downgrades | 3 months ago |
Doximity IncDOCS | 8 | Hold | $18.00 | -27.15% | Downgrades | 4 months ago |
Starz Entertainment CorpSTRZ | 2 | Buy | $30.00 | +18.48% | Upgrades | 4 months ago |
Wixcom LtdWIX | 2 | Hold | $90.00 | +19.17% | Downgrades | 6 months ago |
Integral Ad Science Holding CorpIAS | 3 | Hold | $10.30 | -0.39% | Maintains | a year ago |
Tko Group Holdings IncTKO | 2 | Buy | $250.00 | +31.83% | Maintains | a year ago |
Waystar Holding CorpWAY | 1 | Buy | $44.00 | N/A | Initiates Coverage On | a year ago |
Duolingo IncDUOL | 1 | Hold | $280.00 | N/A | Initiates Coverage On | a year ago |
Dolby Laboratories IncDLB | 1 | Hold | $74.00 | N/A | Initiates Coverage On | a year ago |
Spotify Technology SaSPOT | 3 | Buy | $730.00 | N/A | Maintains | a year ago |
Doubleverify Holdings IncDV | 4 | Hold | $14.00 | N/A | Downgrades | a year ago |
Trade Desk IncTTD | 4 | Buy | $145.00 | N/A | Maintains | 2 years ago |
Godaddy IncGDDY | 8 | Buy | $225.00 | N/A | Maintains | 2 years ago |
Definitive Healthcare CorpDH | 4 | Hold | $5.00 | N/A | Maintains | 2 years ago |
R1 Rcm IncRCM | 3 | Buy | $18.00 | N/A | Maintains | 2 years ago |
Squarespace IncSQSP | 3 | Hold | $44.00 | N/A | Downgrades | 2 years ago |
Hims & Hers Health IncHIMS | 1 | Hold | $10.00 | N/A | Initiates Coverage On | 3 years ago |
Match Group IncMTCH | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 3 years ago |
Bumble IncBMBL | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 3 years ago |
Signify Health IncSGFY | 3 | Hold | $30.50 | N/A | Downgrades | 4 years ago |
Goodrx Holdings IncGDRX | 3 | Hold | $6.00 | N/A | Maintains | 4 years ago |
Innovage Holding CorpINNV | 1 | Hold | $5.00 | N/A | Downgrades | 4 years ago |
Soc Telemed IncTLMD | 1 | Hold | $3.00 | N/A | Downgrades | 5 years ago |
Tabula Rasa Healthcare IncTRHC | 1 | Hold | $11.00 | N/A | Downgrades | 5 years ago |
Cerner CorpCERN | 1 | Hold | $82.00 | N/A | Initiates Coverage On | 5 years ago |
Talkspace IncTALK | 3 | Hold | $3.00 | N/A | Downgrades | 5 years ago |
Accolade IncACCD | 1 | Buy | $54.00 | N/A | Upgrades | 5 years ago |
Oak Street Health IncOSH | 1 | Buy | $60.00 | N/A | Initiates Coverage On | 5 years ago |
1life Healthcare IncONEM | 2 | Hold | $31.00 | N/A | Downgrades | 5 years ago |
Certara IncCERT | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.